These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3092311)

  • 41. [Tolerance of a new intravenously applied immunoglobulin preparation and its effect on serum globulin levels].
    Hansi W; Heimpel H; Barandun S; Lutz O
    Infection; 1982; 10(6):347-51. PubMed ID: 6185438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.
    Ochs HD; Fischer SH; Wedgwood RJ; Wara DW; Cowan MJ; Ammann AJ; Saxon A; Budinger MD; Allred RU; Rousell RH
    Am J Med; 1984 Mar; 76(3A):78-82. PubMed ID: 6424461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency.
    Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins.
    Stein MR
    Postgrad Med; 2010 Sep; 122(5):176-84. PubMed ID: 20861601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The product: All intravenous immunoglobulins are not equivalent.
    Siegel J
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):78S-84S. PubMed ID: 16229678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticomplementary activity and the safety of intravenous immunoglobulin.
    Rousell RH; Budinger MD; Keppler DC; Victor R; Minaga T
    Clin Ther; 1989; 11(1):143-50. PubMed ID: 2497981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anaphylactic shock reaction following intravenous administration of 7S immunoglobulin in patients with hypogammaglobulinemia, especially in children with acute lymphoblastic leukemia (ALL)].
    Manzke H; Seifert J
    Klin Padiatr; 1987; 199(4):274-8. PubMed ID: 3116320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.
    Sorensen RU; Polmar SH
    Am J Med; 1984 Mar; 76(3A):83-90. PubMed ID: 6424462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
    Eijkhout HW; van Der Meer JW; Kallenberg CG; Weening RS; van Dissel JT; Sanders LA; Strengers PF; Nienhuis H; Schellekens PT;
    Ann Intern Med; 2001 Aug; 135(3):165-74. PubMed ID: 11487483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults.
    Abdou NI; Greenwell CA; Mehta R; Narra M; Hester JD; Halsey JF
    Int Arch Allergy Immunol; 2009; 149(3):267-74. PubMed ID: 19218820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease.
    Arai H; Ichimiya Y; Shibata N; Nakajima T; Sudoh S; Tokuda T; Sujaku T; Yokokawa S; Hoshii N; Noguchi H; Bille A
    Psychogeriatrics; 2014 Sep; 14(3):165-74. PubMed ID: 25186799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.
    Mahadevia PJ
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
    Hughes RA; Donofrio P; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Latov N; Merkies IS; van Doorn PA;
    Lancet Neurol; 2008 Feb; 7(2):136-44. PubMed ID: 18178525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. I.v. immune globulin: efficacy and safety.
    Minnefor AB; Oleske JM
    Hosp Pract (Off Ed); 1987 Oct; 22(10):171-3, 177-9, 182-3 passim. PubMed ID: 2443521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.
    Montanaro A; Pirofsky B
    Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.
    Pediatrics; 1997 Jan; 99(1):93-9. PubMed ID: 8989345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.
    Leiva LE; Monjure H; Sorensen RU
    J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune globulin intravenous replacement after plasma exchange.
    Dau PC
    J Clin Apher; 1983; 1(2):104-8. PubMed ID: 6681480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.
    Stein MR; Nelson RP; Church JA; Wasserman RL; Borte M; Vermylen C; Bichler J;
    J Clin Immunol; 2009 Jan; 29(1):137-44. PubMed ID: 18814020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.